Tuberculosis

Policymakers and clinicians in global health often face considerable uncertainty when making decisions. While statistical uncertainty can be accounted for by placing confidence intervals on the estimated impacts of different policies and treatment regimes, “deep” uncertainty poses a more...

The Global Fund to Fight AIDS, Tuberculosis and Malaria—a pioneer in global health since 2002—has helped combat preventable diseases throughout the world. But this work is far from finished. In 2018, 40 percent of people living with HIV did not have access to treatment. TB incidence has ...

In March, our team at the Center for Global Development and Office of Health Economics posted a consultation draft of a policy proposal for a Market-Driven, Value-Based Advanced Commitment (MVAC). The MVAC is a new mechanism that puts middle-income country governments in the driver’s...

Innovation is a critical tool in the global fight against disease—especially for tuberculosis (TB), an infectious disease that primarily affects the poor and vulnerable and ranks among the top 10 causes of death in the world.

CGD experts explain how the BRICS—home to 40 percent of all cases last year—could provide much-needed leadership on the global TB agenda.

This week, the Global Fund partnership will meet in Tokyo to plan for its fifth voluntary replenishment, covering the period 2017-2019. The stakes are high: in an austere budget climate, the Global Fund’s ability to raise the needed resources—and then to spend them effectively over the s...